Cough And Cold Preparations Global Market Report 2024

Description

Cold and cough preparations encompass medications designed to alleviate symptoms associated with these conditions. These drugs target receptors where the infecting virus attaches, countering the receptor's action, eradicating viral infection, and reducing congestion by breaking down mucus and expanding constricted bronchioles.

Primary drug categories in cold and cough preparations consist of antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and other similar treatments. Antihistamines mitigate histamine's effects and are commonly used to address allergies. Varieties include bronchodilators, anticholinergic, and pulmonary antihypertensives. These medications are available in various forms such as oral syrups, tablets, nasal drops, lozenges, and others. Distribution occurs through hospital pharmacies, retail pharmacies, drug stores, and similar channels.

The cold and cough preparations market research report is one of a series of new reports from The Business Research Company that provides cold and cough preparations market statistics, including cold and cough preparations industry global market size, regional shares, competitors with a cold and cough preparations market share, detailed cold and cough preparations market segments, market trends and opportunities, and any further data you may need to thrive in the cold and cough preparations industry. This cold and cough preparations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cough and cold preparations market size has grown strongly in recent years. It will grow from $80.96 billion in 2023 to $85.36 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. Historical growth can be attributed to several factors, including the increased prevalence of respiratory diseases, higher rates of tobacco smoking, global warming, robust economic growth in emerging markets, and an upsurge in healthcare expenditure.

The cough and cold preparations market size is expected to see strong growth in the next few years. It will grow to $104.31 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. Forecasted growth stems from the rise in e-cigarettes/vaping, increasing obesity rates, a sizable undiagnosed population, and government initiatives. Major trends include probiotics for asthma, advanced bronchodilators, new product launches, market collaborations, personalized medicines, aerosol respiratory drugs, generic respiratory drugs, and combination therapy for COPD.

The growth of the cough and cold preparations market is anticipated to be fueled by the rising incidence of allergies in the forecast period. Respiratory allergies, including those triggered by pollen, dust, mold, and pet dander, are on the ascent due to contaminated outdoor and indoor air. Cough and cold preparations are commonly used to address allergies that manifest as coughs and respiratory issues. For example, the European Academy of Allergy and Clinical Immunology projects that by 2025, one in every three people in the European Union will be affected by allergies. This surge in respiratory allergies is expected to drive demand for cough and cold preparations, positively influencing market growth.

The growth of the cough and cold preparations market is expected to receive a boost from the increasing geriatric population. The elderly, aged 65 and older, often have weaker immune systems, making them more susceptible to respiratory infections such as coughs and colds. This heightened vulnerability contributes to a greater demand for cough and cold remedies. According to a report by the World Health Organization (WHO) in October 2022, one in six people globally is expected to be 60 or older by 2030. The worldwide population of individuals aged 80 or older is projected to increase by 426 million between 2020 and 2050. This demographic shift toward an aging population is a significant driver of the growth in the cough and cold preparations market.

Advancements in technologies are playing a pivotal role in shaping the global pharmaceutical sector, and this impact extends to cold and cough preparations. As outlined in a global life sciences report by Deloitte, various cutting-edge technologies are driving the life sciences sector, including the pharmaceutical domain. Some of these transformative technologies include AI, robotic automation, the Internet of Medical Things (IoMT), blockchain, DIY diagnostics, virtual care, mobility in drug delivery and clinical trials, genomics, next-generation therapies, cloud computing, Real-World Evidence (RWE), and data-driven precision medicine. AI technology is being harnessed for diagnoses, treatment planning, patient monitoring, and drug discovery. The IoMT is facilitating the emergence of new business models and enhancing customer experiences. Biomarkers, which are biological indicators objectively measured and evaluated for various processes, are increasingly being utilized in the drug development process to expedite product launches.

Major companies in the cough and cold preparations market are responding to these technological advancements by developing new products, such as herbal cough syrups, to cater to larger customer bases, drive more sales, and increase revenue. Herbal cough syrups are liquid formulations made from natural or plant-based ingredients, typically incorporating herbs, botanical extracts, and other organic compounds. These products aim to alleviate symptoms of coughs and colds. For example, Dexa Medica, an Indonesia-based pharmaceutical company, launched Herbacough in May 2021. Herbacough is a herbal cough syrup known for its unique qualities, including the absence of side effects or addictive tendencies. Positioned as an effective treatment for various types of coughs, Herbacough boasts benefits such as soothing sore throats, easing breathing, warming the respiratory tract, and relieving different forms of coughs. The product employs the latest fractionation technology, an extraction method isolating a specific active substance, reconyl, making it a safe and efficient remedy for cough and sore throat issues.

The cold and cough preparations market is subject to regulatory oversight by authorities, such as the Food and Drug Administration (FDA) in the United States. An example of regulatory action is the FDA's restriction on the use of codeine in children. Codeine, although approved for pain and cough treatment, poses serious risks, including the potential for slowed or difficult breathing, and can be fatal. The FDA has recognized a higher risk of these adverse effects in children under the age of 12, leading to restrictions on the use of codeine even in some older children. Single-ingredient codeine is FDA-approved solely for use in adults. Additionally, the FDA recommends against the use of codeine in breastfeeding mothers due to the potential harm it may pose to their infants. This regulatory intervention reflects a commitment to ensuring the safety of pharmaceutical products, especially those intended for vulnerable populations such as children and breastfeeding mothers.

Major companies operating in the cough and cold preparations market report are Johnson & Johnson, GlaxoSmithKline PLC, Procter & Gamble, Bayer AG, Reckitt Benckiser Group PLC, Novartis AG, Perrigo Company, Sun Pharmaceutical Industries Ltd., Prestige Consumer Healthcare, Blackmores Limited, AFT Pharmaceuticals, Dexa Medica, Glenmark Pharmaceuticals Limited, Wockhardt Ltd., Apnar Pharma LP, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd. , China National Pharmaceutical Group Co., Ltd., Shanghai Anovent Pharma, Shanghai Acebright Pharmaceuticals Group Co., Ltd., China Meheco Group Co., Ltd. , Merck & Co, Abbott Laboratories, Boehringer Ingelheim, Roche Holding AG, Vectura Group, Pfizer, Mylan, Teva Pharmaceutical Industries Ltd., Sanofi, W. K. Buckley Limited, BENYLIN, Sanfer, PROBIOMED, PiSA, EMS Pharma, Hypermarcas, Ache, Eurofarma, Biolab Farmaceuticad, Cristalia, Libbs, AstraZeneca, Neopharma, Regal Pharmaceuticals, Adcock Ingram, Aspen Pharmacare

North America was the largest region in the cold and cough preparation market share in 2023. Middle East is expected to be the fastest-growing region in the global cough and cold preparations market during the forecast period. The regions covered in the cough and cold preparations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cough and cold preparations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The cold and cough preparations market consists of sales of dextromethorphan, guaifenesin, and phenylephrine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cough And Cold Preparations Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cough and cold preparations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cough and cold preparations? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cough and cold preparations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Drug Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Antibiotics; Other Drug Types.
2) By Dosage Type: Oral Syrups; Tablets/Pills; Nasal Drops; Lozenges; Other Dosage Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Other Distribution Channels
Companies Mentioned: Johnson & Johnson; GlaxoSmithKline plc; Procter & Gamble; Bayer AG; Reckitt Benckiser Group plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r14392

1. Executive Summary

2. Cough And Cold Preparations Market Characteristics

3. Cough And Cold Preparations Market Trends And Strategies

4. Cough And Cold Preparations Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Cough And Cold Preparations Market Size and Growth

5.1. Global Cough And Cold Preparations Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cough And Cold Preparations Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cough And Cold Preparations Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cough And Cold Preparations Market Segmentation

6.1. Global Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Bronchodialators
Anticholinergic
Pulmonary Antihypertensives
6.2. Global Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Other Types
6.3. Global Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral Syrups
Tablets/Pills
Nasal Drops
Lozenges
Other Dosage Types
6.4. Global Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Drug Stores

7. Cough And Cold Preparations Market Regional And Country Analysis

7.1. Global Cough And Cold Preparations Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cough And Cold Preparations Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cough And Cold Preparations Market

8.1. Asia-Pacific Cough And Cold Preparations Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cough And Cold Preparations Market

9.1. China Cough And Cold Preparations Market Overview
9.2. China Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cough And Cold Preparations Market

10.1. India Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cough And Cold Preparations Market

11.1. Japan Cough And Cold Preparations Market Overview
11.2. Japan Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cough And Cold Preparations Market

12.1. Australia Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cough And Cold Preparations Market

13.1. Indonesia Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cough And Cold Preparations Market

14.1. South Korea Cough And Cold Preparations Market Overview
14.2. South Korea Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cough And Cold Preparations Market

15.1. Western Europe Cough And Cold Preparations Market Overview
15.2. Western Europe Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cough And Cold Preparations Market

16.1. UK Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cough And Cold Preparations Market

17.1. Germany Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cough And Cold Preparations Market

18.1. France Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cough And Cold Preparations Market

19.1. Italy Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cough And Cold Preparations Market

20.1. Spain Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cough And Cold Preparations Market

21.1. Eastern Europe Cough And Cold Preparations Market Overview
21.2. Eastern Europe Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cough And Cold Preparations Market

22.1. Russia Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cough And Cold Preparations Market

23.1. North America Cough And Cold Preparations Market Overview
23.2. North America Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cough And Cold Preparations Market

24.1. USA Cough And Cold Preparations Market Overview
24.2. USA Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cough And Cold Preparations Market

25.1. Canada Cough And Cold Preparations Market Overview
25.2. Canada Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cough And Cold Preparations Market

26.1. South America Cough And Cold Preparations Market Overview
26.2. South America Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cough And Cold Preparations Market

27.1. Brazil Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cough And Cold Preparations Market

28.1. Middle East Cough And Cold Preparations Market Overview
28.2. Middle East Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cough And Cold Preparations Market

29.1. Africa Cough And Cold Preparations Market Overview
29.2. Africa Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cough And Cold Preparations Market Competitive Landscape And Company Profiles

30.1. Cough And Cold Preparations Market Competitive Landscape
30.2. Cough And Cold Preparations Market Company Profiles
- 30.2.1. Johnson & Johnson
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. GlaxoSmithKline plc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Procter & Gamble
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Reckitt Benckiser Group plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Cough And Cold Preparations Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Perrigo Company
31.3. Sun Pharmaceutical Industries Ltd.
31.4. Prestige Consumer Healthcare
31.5. Blackmores Limited
31.6. AFT Pharmaceuticals
31.7. Dexa Medica
31.8. Glenmark Pharmaceuticals Limited
31.9. Wockhardt Ltd
31.10. Apnar Pharma LP
31.11. Hanmi Pharmaceutical
31.12. Cipla Limited
31.13. Aurobindo Pharma Limited
31.14. KYORIN Holdings, Inc
31.15. Nichi-Iko Pharmaceutical Co., Ltd

32. Global Cough And Cold Preparations Market Competitive Benchmarking

33. Global Cough And Cold Preparations Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cough And Cold Preparations Market

35. Cough And Cold Preparations Market Future Outlook and Potential Analysis

35.1 Cough And Cold Preparations Market In 2028 - Countries Offering Most New Opportunities
35.2 Cough And Cold Preparations Market In 2028 - Segments Offering Most New Opportunities
35.3 Cough And Cold Preparations Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer